نتائج البحث - "Glucagon-Like Peptide-1 Receptor"

1

Effect of Empagliflozin and Liraglutide on the Nucleotide-Binding and Oligomerization Domain-Like Receptor Family Pyrin Domain-Containing 3 Inflammasome in a Rodent Model of Type 2 Diabetes Mellitus

المؤلفون: Patrick Meagher, Mark Gordon, Kim A. Connelly

المصدر: Canadian Journal of Diabetes. 45:553-556

مصطلحات موضوعية: Male, Inflammasomes, medicine.drug_class, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Type 2 diabetes, Pharmacology, Pyrin domain, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Glucosides, NLR Family, Pyrin Domain-Containing 3 Protein, Internal Medicine, medicine, Empagliflozin, Animals, 030212 general & internal medicine, Benzhydryl Compounds, Receptor, Sodium-Glucose Transporter 2 Inhibitors, Liraglutide, business.industry, Type 2 Diabetes Mellitus, Inflammasome, General Medicine, medicine.disease, Receptor antagonist, Rats, Disease Models, Animal, Diabetes Mellitus, Type 2, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::236da61807a9efbc3204c8e49a0dd8c1Test
https://doi.org/10.1016/j.jcjd.2020.11.003Test

2

Surpassing insulin glargine in type 2 diabetes with tirzepatide

المؤلفون: Tricia Tan, Bernard Khoo

المصدر: The Lancet. 398:1779-1781

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a2ac534e1b0ab86b32e38d5103f6d4cTest
https://doi.org/10.1016/s0140-6736Test(21)02279-0

3

Glucagon-like peptide-1 receptor agonists or sodium–glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta-analysis of surrogate metabolic endpoints

المؤلفون: Christodoulos Papadopoulos, Maria-Styliani Kalogirou, Konstantinos Imprialos, Michael Doumas, Dimitrios Patoulias, Alexandra Katsimardou, Maria Toumpourleka, Konstantinos Stavropoulos, I. Stergiou, Ioanna Zografou

المصدر: Diabetes & Metabolism. 46:272-279

مصطلحات موضوعية: Blood Glucose, Diarrhea, medicine.medical_specialty, endocrine system diseases, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Lower risk, Reproductive Tract Infections, Glucagon-Like Peptide-1 Receptor, law.invention, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Randomized controlled trial, law, Internal medicine, Internal Medicine, Humans, Hypoglycemic Agents, Medicine, Adverse effect, Sodium-Glucose Transporter 2 Inhibitors, Glucagon-like peptide 1 receptor, Glycated Hemoglobin, business.industry, digestive, oral, and skin physiology, nutritional and metabolic diseases, Type 2 Diabetes Mellitus, Nausea, General Medicine, medicine.disease, Hypoglycemia, Metformin, Discontinuation, Diabetes Mellitus, Type 2, Drug Therapy, Combination, business, hormones, hormone substitutes, and hormone antagonists, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ce3d6027343af920dadd3558513e6e5Test
https://doi.org/10.1016/j.diabet.2020.04.001Test

4

The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial

المصدر: The Lancet Diabetes & Endocrinology. 8:106-114

مصطلحات موضوعية: Male, medicine.medical_specialty, Recombinant Fusion Proteins, Endocrinology, Diabetes and Metabolism, Glucagon-Like Peptides, 030209 endocrinology & metabolism, Type 2 diabetes, Placebo, Incretins, Glucagon-Like Peptide-1 Receptor, law.invention, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Double-Blind Method, Randomized controlled trial, Modified Rankin Scale, law, Internal medicine, Internal Medicine, Clinical endpoint, Humans, Hypoglycemic Agents, Medicine, Prospective Studies, 030212 general & internal medicine, Stroke, Glycated Hemoglobin, business.industry, Hazard ratio, Middle Aged, medicine.disease, Immunoglobulin Fc Fragments, Treatment Outcome, Diabetes Mellitus, Type 2, Female, Dulaglutide, business, Diabetic Angiopathies, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::650198a64065c9515c8db9905df031e1Test
https://doi.org/10.1016/s2213-8587Test(19)30423-1

5

Anti-inflammatory properties of antidiabetic drugs: A 'promised land' in the COVID-19 era?

المؤلفون: Niki Katsiki, Ele Ferrannini

المصدر: Journal of Diabetes and its Complications
Journal of Diabetes and Its Complications

مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, Anti-Inflammatory Agents, Interleukin 6, 030209 endocrinology & metabolism, Comorbidity, 030204 cardiovascular system & hematology, Saxagliptin, Linagliptin, Bioinformatics, Article, Glucagon-like peptide-1 receptor agonists, Glucagon-Like Peptide-1 Receptor, C-reactive protein, 03 medical and health sciences, chemistry.chemical_compound, Lixisenatide, 0302 clinical medicine, Endocrinology, Risk Factors, medicine, Internal Medicine, Humans, Hypoglycemic Agents, Dapagliflozin, Sodium-Glucose Transporter 2 Inhibitors, Inflammation, Canagliflozin, Ferritin, Dipeptidyl-Peptidase IV Inhibitors, Pioglitazone, SARS-CoV-2, business.industry, Semaglutide, Sitagliptin Phosphate, COVID-19, Metformin, Dipeptidyl peptidase 4 inhibitors, Diabetes Mellitus, Type 2, chemistry, business, Exenatide, Sodium-glucose co-transporter-2 inhibitors, Alogliptin, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c7d259d2b2320def71dbaf69d67c50fTest

6

Time and metabolic state-dependent effects of GLP-1R agonists on NPY/AgRP and POMC neuronal activity in vivo

المؤلفون: J. Nicholas Betley, Briana Wallace, Anita Kabahizi, Linh Lieu, Nitsan Goldstein, Dominic Chau, Kevin W. Williams, Jamie R. E. Carty, Eun-Sang Hwang, Yunqian Peng, Zhenyan He, Yanbin Dong, Yong Gao, Ling Hu

المصدر: Molecular Metabolism, Vol 54, Iss, Pp 101352-(2021)
Molecular Metabolism

مصطلحات موضوعية: Male, Agonist, endocrine system, medicine.medical_specialty, Pro-Opiomelanocortin, Time Factors, medicine.drug_class, Injections, Subcutaneous, Glucagon-Like Peptides, Mice, Transgenic, TRPC5 subunit, Glucagon-Like Peptide-1 Receptor, Mice, Glutamatergic, GLP-1R Agonists on NPY/AgRP neuron, Proopiomelanocortin, Internal medicine, medicine, Animals, Premovement neuronal activity, Agouti-Related Protein, Neuropeptide Y, Molecular Biology, Metabolic state-dependent effects, Mice, Knockout, Neurons, biology, Chemistry, Liraglutide, Semaglutide, digestive, oral, and skin physiology, Cell Biology, Neuropeptide Y receptor, RC31-1245, Endocrinology, nervous system, Liraglutide and semaglutide, biology.protein, GABAergic, Original Article, Long-acting glucagon-like peptide-1 receptor agonists (GLP-1RAs), Injections, Intraperitoneal, hormones, hormone substitutes, and hormone antagonists, POMC Neuronal activity, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ef71564013db991533eb900a5dd97fdTest
https://doi.org/10.1016/j.molmet.2021.101352Test

7

Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β

المؤلفون: Yanqiu Deng, Peng Peng, Zhongya Gu, Gang Zhao, Shuyi Chen, Mei Zhou, Jing Yu

المصدر: Biochemical and Biophysical Research Communications. 511:154-160

مصطلحات موضوعية: Male, 0301 basic medicine, Agonist, medicine.medical_specialty, medicine.drug_class, Recombinant Fusion Proteins, Glucagon-Like Peptides, Intermediate Filaments, Biophysics, Hyperphosphorylation, Morris water navigation task, tau Proteins, Biochemistry, Glucagon-Like Peptide-1 Receptor, Streptozocin, 03 medical and health sciences, 0302 clinical medicine, Alzheimer Disease, Memory, Internal medicine, medicine, Animals, Hypoglycemic Agents, Memory impairment, Phosphorylation, Maze Learning, Molecular Biology, Protein kinase B, PI3K/AKT/mTOR pathway, Memory Disorders, Glycogen Synthase Kinase 3 beta, biology, business.industry, Cell Biology, Immunoglobulin Fc Fragments, Mice, Inbred C57BL, Insulin receptor, 030104 developmental biology, Endocrinology, 030220 oncology & carcinogenesis, biology.protein, Dulaglutide, business, Signal Transduction, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7d1346a6a3ba632ac556437a2839d1eTest
https://doi.org/10.1016/j.bbrc.2019.01.103Test

8

Identification of expression and function of the glucagon-like peptide-1 receptor in colonic smooth muscle

المؤلفون: John R. Grider, Alexander T. May, Molly S. Crowe, Sunila Mahavadi, Hongxia Wang, Karnam S. Murthy, Bryan A. Blakeney

المصدر: Peptides. 112:48-55

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fbeae47d8dc198361354471c71ca4d9Test
https://doi.org/10.1016/j.peptides.2018.11.007Test

9

Sitagliptin attenuates intestinal ischemia/reperfusion injury via cAMP/PKA, PI3K/Akt pathway in a glucagon-like peptide 1 receptor-dependent manner

المؤلفون: Rehab M. Khedr, Rehab Kamel, Amany A.E. Ahmed, Eman M. Raafat

المصدر: Life Sciences. 211:31-39

مصطلحات موضوعية: Male, 0301 basic medicine, medicine.medical_specialty, Apoptosis, Glucagon-Like Peptide-1 Receptor, General Biochemistry, Genetics and Molecular Biology, Rats, Sprague-Dawley, Phosphatidylinositol 3-Kinases, 03 medical and health sciences, 0302 clinical medicine, Glucagon-Like Peptide 1, Internal medicine, Cyclic AMP, medicine, Animals, Hypoglycemic Agents, Intestinal Mucosa, General Pharmacology, Toxicology and Pharmaceutics, Receptor, Protein kinase B, Glucagon-like peptide 1 receptor, PI3K/AKT/mTOR pathway, Inflammation, Akt/PKB signaling pathway, Chemistry, Sitagliptin Phosphate, General Medicine, medicine.disease, Cyclic AMP-Dependent Protein Kinases, Glucagon-like peptide-1, Rats, Intestines, Intestinal Diseases, 030104 developmental biology, Endocrinology, Gene Expression Regulation, Reperfusion Injury, 030220 oncology & carcinogenesis, Sitagliptin, Inflammation Mediators, Proto-Oncogene Proteins c-akt, Reperfusion injury, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48ad04e8b54d4809f17ef649701b8589Test
https://doi.org/10.1016/j.lfs.2018.09.013Test

10

Cardiovascular outcome studies in type 2 diabetes: Comparison between SGLT2 inhibitors and GLP-1 receptor agonists

المؤلفون: André Scheen

المصدر: Diabetes Research and Clinical Practice. 143:88-100

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42e36ba3d68bfe05a7bd1255d3ddc332Test
https://doi.org/10.1016/j.diabres.2018.06.008Test

تنقيح النتائج